中国临床药理学与治疗学2024,Vol.29Issue(5) :590-595.DOI:10.12092/j.issn.1009-2501.2024.05.015

氧化三甲胺影响冠心病和抗血小板药物疗效的研究进展

Research progress of the effect of TMAO on coronary heart disease and the efficacy of antiplatelet drugs

彭园园 陈碧莲
中国临床药理学与治疗学2024,Vol.29Issue(5) :590-595.DOI:10.12092/j.issn.1009-2501.2024.05.015

氧化三甲胺影响冠心病和抗血小板药物疗效的研究进展

Research progress of the effect of TMAO on coronary heart disease and the efficacy of antiplatelet drugs

彭园园 1陈碧莲1
扫码查看

作者信息

  • 1. 中南大学湘雅医院老年医学科,长沙 410078,湖南
  • 折叠

摘要

冠心病目前仍是全球范围(包括中国)最常见的心血管疾病和死亡原因之一.抗血小板药物是治疗冠心病的基础性药物.近年来越来越多的研究发现,肠道菌群主要代谢产物氧化三甲胺(trimethylamine N-oxide,TMAO)可通过多种机制促进动脉粥样硬化,影响冠心病患者的预后和抗血小板药物的疗效.本文就这方面的研究进行综述.

Abstract

Coronary heart disease is still one of the most common cardiovascular disease and causes of death worldwide(including China).Anti-platelet drugs are fundamental in the treatment of coronary heart disease.In recent years,more and more studies have found that trimethylamine N-ox-ide(TMAO),a major metabolite of intestinal flora,can promote atherosclerosis through various mech-anisms,affecting the prognosis of patients with cor-onary heart disease and the efficacy of antiplatelet drugs.This article reviews the effect of TMAO on coronary heart disease and the efficacy of anti-platelet drugs.

关键词

氧化三甲胺/冠心病/抗血小板药物

Key words

trimethylamine N-oxide/coronary heart disease/antiplatelet drug

引用本文复制引用

基金项目

湖南省科技厅科研项目(2022JJ70156)

长沙市科技局科研项目(kq2202367)

出版年

2024
中国临床药理学与治疗学
中国药理学会

中国临床药理学与治疗学

CSTPCD北大核心
影响因子:0.97
ISSN:1009-2501
参考文献量26
段落导航相关论文